Description
Each year, AAPS elevates a few members to Fellow
in recognition of their professional excellence and sustained superior impact
in fields relevant to AAPS’s mission. A nomination package is a carefully
prepared dossier that details the nominee’s contributions to the body
of science. The directions for completing a nomination are specified in the
Fellows Handbook (PDF).
Join 2023 AAPS Fellows Committee Chair Mandip
Singh Sachdeva, Ph.D., FAAPS, and an esteemed panel for an overview of the
Fellows nomination process, including details about the
new service
requirement
all nominees must meet to be considered, and the confidential
professional conduct disclosure form
all nominees must complete.
A recording of this presentation will be made
available to AAPS members in the
on-demand
webinar archive
.
Contributors
-
Mandip Singh Sachdeva, Ph.D., FAAPS
Mandip Sachdeva, Ph.D., is the Fellows Committee Chair for 2023. Dr. Mandip Sachdeva has been commended globally for his scientific research work and has contributed over four decades of dedicated service towards Pharmaceutical Education, Research and Industry. A widely travelled scientist, he has delivered more than 250 plenaries, keynote and invited talks in USA, Canada, India, Dubai, Brazil, Netherlands, Belgium and numerous other international events and meetings. He has guided 28 Ph.D.’s, 31 Post-Doctorates, and scores of postgraduate and undergraduate students. He has been Editor-in-Chief for CRC Critical Reviews in Therapeutic Drug Carrier Systems (current impact factor of 4.89), since 2009. He has to his credit over 180 original publications, one edited book and 6 book chapters, with Google H-index of 52, i10-index of 225 and over 11500 citations. Based on his published work, Stanford Univ., USA, has recognized him among Top 2% scientists across the world in 2020, 2021 and 2022.
Mandip Singh Sachdeva is currently a Professor and Section leader, Pharmaceutics at College of Pharmacy at Florida A & M University (FAMU), Tallahassee, Florida, USA. He got his M.Sc. and Ph.D. of Biopharmaceutics from Dalhousie University, Canada, in 1986 and 1989, respectively. He then worked with SynPhar laboratories in Edmonton, Canada, as a Group Leader, Drug Targeting, during 1989-93, and then moved to academia as an Assistant Professor, Pharmaceutics, at Florida A&M University in 1993 and got promoted to Full Professor in 2002.
Dr. Sachdeva has won several honors and awards such as Novapharm Award for the 1989-1990 for Excellence in Biopharmaceutics, AAPS Fellow Award 2007, Davis Productivity Award from the State of Florida, 2009, 2011 and 2014, Research Excellence Award 2011 from FAMU, and Distinguished Researcher Award in 2017. He was also selected as a Fulbright Fellow 2014-15 and again in 2022-23. He was also selected as a GIAN Fellow in 2016 to perform outreach activities in India. He was bestowed with the Elizabeth Hurlock Beckman Award in 2020, which is awarded to mentors who have made stellar difference in the community. He has been consistently funded for over 25 years by various agencies like NIH, NASA, US Department of Defense, and US National Science Foundation, and has brought over 30 million USD in research funding to his institution. Further, he has organized several symposia for the AAPS National meetings as well as has been speaker and moderator for several other AAPS symposia too. A senior member for the National Academy of inventors, he has 10 issued US patents to his own credit. He is an elected member for Controlled Release Society (CRS), American Association of Pharmaceutical Scientists (AAPS), American Association of Cancer Research (AACR), Society of Toxicology, and Society of Investigative Dermatology. Further, he has been the Chair of the Dermatopharmaceutics Focus group at AAPS during 2014-16. Currently, he is the Chair for the AAPS Nanotechnology community. His research interests include cancer drug delivery (breast and lung cancer), 3D-printing of tumor cells and human cornea, topical and transdermal delivery, formulating and developing targeted nanoparticles, exosomes and inhalation delivery of pharmaceuticals.
-
Joan Korth-Bradley, Pharm.D., Ph.D., FAAPS
Dr. Korth-Bradley is the Fellows Committee Vice Chair. She is a seasoned professional with 25+ years of experience at Pfizer. In her current role as Senior Director, Clinical Pharmacology in Global Product Development, she designs and implements clinical pharmacology studies that support development plans. Joan has been a change agent in significant transformations within the R&D organizations at Wyeth and Pfizer. She has a keen sense of what makes individuals successful in embracing change. As a respected, long-time employee at Pfizer, Joan has the informal role of “Mother Auntie Elephant” in her organization. She uses her persistent curiosity and the wisdom learnings of her vast experience to help translate the vision of senior leaders into tangible actions for other employees trying to adapt to change. Because of her involvement, senior leaders better understand how transformation should happen and employees are clearer about why the change is needed. Joan holds a PhD in Pharmacokinetics Pharmaceutics from the University of Texas at Austin. She is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and the American College of Clinical Pharmacology (ACCP).
-
Reina Bendayan, Pharm.D., FAAPS, University of Toronto
Dr. Reina Bendayan is the Fellows Committee Past Chair for 2023. She is a Professor, Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto and Career Scientist, Ontario HIV treatment Network, Ministry of Health of Ontario (MHO). After obtaining a Bachelor of Sciences in Pharmacy and a Hospital Pharmacy Residency Program at the University of Montreal, Dr. Bendayan completed a Doctor of Pharmacy at the University of Florida and a three-year Medical Research Council Post-Doctoral Fellowship Program in Clinical Pharmacology and Membrane Cell Biology at the University of Toronto. Dr. Bendayan’s research program is primarily focused on Membrane Transport and Therapeutics with an emphasis in the field of HIV/AIDS Antiviral Drug Transport and Regulation at sanctuary sites and cellular reservoirs of HIV. Her research program is primarily funded by the Canadian Institutes of Health Research, Natural Sciences Engineering Research Council and MHO. She is the author of over 100 peer-reviewed manuscripts and has supervised many graduate students and post-doctoral research fellows. She is a member of several scientific associations: AAPS, ASPET, IBBS, IAS and CSPS. Dr. Bendayan was elected FELLOW of the AAPS and CSPS. She received the Association of Faculties of Pharmacy of Canada Research Career Award and the CSPS Research Leadership Award.
-
Dale Eric Wurster, Ph.D., FAAPS
Dale Eric Wurster is the Fellows Task Force Chair. Dr. Wurster received his B.S. Degree (Chemistry) from the University of Wisconsin-Madison in 1974. The Ph.D. Degree (Industrial and Physical Pharmacy) was granted in 1979 by Purdue University. Upon graduation, Wurster joined the faculty of the University of North Carolina-Chapel Hill as an Assistant Professor. Since 1982 he has been on the faculty of the University of Iowa (Division of Pharmaceutics and Translational Therapeutics). He was promoted to Associate Professor in 1987 and to Professor in 1996. From 2006 to 2012 he was also a Professor in the University of Iowa Department of Chemical and Biochemical Engineering. In addition to his faculty responsibilities, he has been the Associate Dean for Academic Affairs of the University of Iowa Graduate College (Jan. 1, 2002 – July 31, 2009) and the Senior Associate Dean of the University of Iowa Graduate College, with primary responsibility for the Academic Affairs Section (Aug. 1, 2009 – June 30, 2015). Wurster became Professor Emeritus of Pharmaceutics on August 1, 2020.
Wurster’s research has largely focused on interactions occurring across interfaces. Analytical techniques which figure prominently in his research are: isoperibol calorimetry, compression calorimetry, differential scanning calorimetry, Fourier-transform Infrared Spectroscopy (FTIR), computer modelling, dynamic vapor sorption, and X-ray photoelectron spectroscopy (XPS). Wurster is the author or co-author of over 200 peer-reviewed abstracts and research articles, and he has served as major professor for 34 Ph.D. students.
Wurster served a three-year term as President Elect (2018), President (2019), and Past President (2020) of the American Association of Pharmaceutical Scientists (AAPS). He is an AAPS Fellow (1998) and the recipient of an AAPS Research Achievement Award in Manufacturing Science and Engineering (2009). He was named a Distinguished Alumnus of the Purdue University College of Pharmacy in 2015, and, in 2017, he was presented with the Ralph Shangraw Memorial Award by the IPEC Foundation. In 2018, Wurster received the David J. W. Grant NIPTE Distinguished Scholar Award in Basic Pharmaceutics, and he was the 2019 Louis W. Busse Lecturer at the University of Wisconsin – Madison School of Pharmacy. Wurster was Chair of the Faculty Committee (July 2017- June 2018) of the National Institute for Pharmaceutical Technology and Education (NIPTE). He also served one term on the Scientific Advisory Board for the Engineering Research Center for Structured Organic Particulate Systems (NSF, 2008 - 2011). Wurster served on various committees of the United States Pharmacopeia for 25 years (1995-2020), and has served on various committees of the National Association of Boards of Pharmacy for 40 years (1982-2022).